Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIPSYCHOTIC-DRUGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 972 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Berlind, A
      Effects of haloperidol and phentolamine on the crustacean cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    2. Berlind, A
      Monoamine pharmacology of the lobster cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    3. Ellis, KA; Nathan, PJ
      The pharmacology of human working memory

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    4. Agelink, MW; Zeit, T; Baumann, B; Majewski, T; Lemmer, W; Postert, T; Lukas, K; Klieser, E
      In vivo cardiovascular effects of the new atypical neuroleptic sertindole

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Devoto, P; Flore, G; Pani, L; Gessa, G
      Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

      MOLECULAR PSYCHIATRY
    6. Mirnics, K; Middleton, FA; Stanwood, GD; Lewis, DA; Levitt, P
      Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

      MOLECULAR PSYCHIATRY
    7. Ohtsuki, T; Sakurai, K; Dou, H; Toru, M; Yamakawa-Kobayashi, K; Arinami, T
      Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

      MOLECULAR PSYCHIATRY
    8. Depatie, L; Lal, S
      Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    9. Ball, MP; Coons, VB; Buchanan, RW
      A program for treating olanzapine-related weight gain

      PSYCHIATRIC SERVICES
    10. Harrison, PJ; Eastwood, SL
      Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

      HIPPOCAMPUS
    11. Beelen, AP; Yeo, KTJ; Lewis, LD
      Asymptomatic QTc prolongation associated with quetiapine fumarate overdosein a patient being treated with risperidone

      HUMAN & EXPERIMENTAL TOXICOLOGY
    12. Lyons, D; McLoughlin, DM
      Recent advances - Psychiatry

      BRITISH MEDICAL JOURNAL
    13. See, RE; Berglind, WJ
      Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol

      NEUROREPORT
    14. Goudie, AJ; Baker, LE; Smith, JA; Prus, AJ; Svensson, KA; Cortes-Burgos, LA; Wong, EHF; Haadsma-Svensson, S
      Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms

      BEHAVIOURAL PHARMACOLOGY
    15. Lucas, G; Di Matteo, V; De Deurwaerdere, P; Porras, G; Martin-Ruiz, R; Artigas, F; Esposito, E; Spampinato, U
      Neurochemical and electrophysiological evidence that 5-HT4 receptors exerta state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function

      EUROPEAN JOURNAL OF NEUROSCIENCE
    16. Legault, M; Wise, RA
      Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission inthe ventral tegmental area

      EUROPEAN JOURNAL OF NEUROSCIENCE
    17. Bustillo, JR; Lauriello, J; Rowland, LM; Jung, RE; Petropoulos, H; Hart, BL; Blanchard, J; Keith, SJ; Brooks, WM
      Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    18. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    19. Salzman, C
      Treatment of the agitation of late-life psychosis and Alzheimer's disease

      EUROPEAN PSYCHIATRY
    20. Scatton, B; Cohen, C; Perrault, G; Oblin, A; Claustre, Y; Schoemaker, H; Sanger, DJ; Rouquier, L; Porsolt, R
      The preclinical pharmacologic profile of tiapride

      EUROPEAN PSYCHIATRY
    21. Konicki, PE; Kwon, KY; Steele, V; White, J; Fuller, M; Jurjus, GJ; Jaskiw, GE
      Prefrontal cortical sulcal widening associated with poor treatment response to clozapine

      SCHIZOPHRENIA RESEARCH
    22. Voruganti, L; Slomka, P; Zabel, P; Costa, G; So, A; Mattar, A; Awad, AG
      Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging

      NEUROPSYCHOPHARMACOLOGY
    23. Scheepers, FE; Wied, CCG; Westenberg, HGM; Kahn, RS
      The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    24. Mukherjee, J; Christian, BT; Narayanan, TK; Shi, BH; Mantil, J
      Evaluation of, dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using F-18-fallypride

      NEUROPSYCHOPHARMACOLOGY
    25. Hemsley, KM; Crocker, AD
      Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra

      NEUROPSYCHOPHARMACOLOGY
    26. Ouagazzal, AM; Grottick, AJ; Moreau, JL; Higgins, GA
      Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains

      NEUROPSYCHOPHARMACOLOGY
    27. Moy, SS; Knapp, DJ; Breese, GR
      Effect of olanzapine on functional responses from sensitized D-1-dopamine receptors in rats with neonatal dopamine loss

      NEUROPSYCHOPHARMACOLOGY
    28. Stine, CD; Lu, WX; Wolf, ME
      Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions

      NEUROPSYCHOPHARMACOLOGY
    29. Jardemark, KE; Ai, JL; Ninan, I; Wang, RY
      Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug

      SYNAPSE
    30. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    31. Rodriguez, JJ; Garcia, DR; Nakabeppu, Y; Pickel, VM
      FosB in rat striatum: Normal regional distribution and enhanced expressionafter 6-month haloperidol administration

      SYNAPSE
    32. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    33. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    34. Schmitt, A; Weber-Fahr, W; Jatzko, A; Tost, H; Henn, FA; Braus, DF
      Structural magnetic resonance imaging in schizophrenia: An overview

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    35. Pollmacher, T; Schuld, A; Kraus, T; Haack, M; Hinze-Selch, D
      On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    36. Baptista, T; Lacruz, A; Meza, T; Contreras, Q; Delgado, C; Mejias, MA; Hernandez, L
      Antipsychotic drugs and obesity: Is prolactin involved?

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    37. Koskinen, T; Sirvio, J
      Studies on the involvement of the dopaminergic system in the 5-HT2 agonist(DOI)-induced premature responding in a five-choice serial reaction time task

      BRAIN RESEARCH BULLETIN
    38. Marek, GJ; Wright, RA; Gewirtz, JC; Schoepp, DD
      A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

      NEUROSCIENCE
    39. Stutzmann, GE; Marek, GJ; Aghajanian, GK
      Adenosine preferentially suppresses serotonin(2a) receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex

      NEUROSCIENCE
    40. Eastwood, SL; Cotter, D; Harrison, PJ
      Cerebellar synaptic protein expression in schizophrenia

      NEUROSCIENCE
    41. Nudmamud, S; Reynolds, GP
      Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia

      NEUROSCIENCE LETTERS
    42. Fadel, J; Dobner, PR; Deutch, AY
      The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat

      NEUROSCIENCE LETTERS
    43. Yoshimura, R; Ueda, N; Nakamura, J
      Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms - Preliminary study

      NEUROPSYCHOBIOLOGY
    44. Yoon, HY; Hwang, SH; Lee, EY; Kim, TU; Cho, EH; Cho, SW
      Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine.

      BIOCHIMIE
    45. Crocker, AD; Hemsley, KM
      An animal model of extrapyramidal side effects induced by antipsychotic drugs: Relationship with D2 dopamine receptor occupancy

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    46. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    47. Silva, JACE; Alvarez, N; Mazzotti, G; Gattaz, WF; Ospina, J; Larach, V; Starkstein, S; Oliva, D; Cousins, L; Tohen, M; Taylor, CC; Wang, J; Tran, PV
      Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    48. Feng, J; Cai, X; Zhao, JH; Yan, Z
      Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons

      JOURNAL OF NEUROSCIENCE
    49. Ahmed, Z; Anderson, IM
      Treatment of bipolar affective disorder in clinical practice

      JOURNAL OF PSYCHOPHARMACOLOGY
    50. Berk, M; Ichim, C; Brook, S
      Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    51. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    52. Sharp, FR; Tomitaka, M; Bernaudin, M; Tomitaka, S
      Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

      TRENDS IN NEUROSCIENCES
    53. Newton, TF; Ling, W; Kalechstein, AD; Uslaner, J; Tervo, K
      Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine

      PSYCHIATRY RESEARCH
    54. Kurzthaler, I; Fleischhacker, WW
      The clinical implications of weight gain in schizophrenia

      JOURNAL OF CLINICAL PSYCHIATRY
    55. Pilowsky, LS
      Probing targets for antipsychotic drug action with PET and SPET receptor imaging

      NUCLEAR MEDICINE COMMUNICATIONS
    56. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    57. Kapur, S
      Neuroimaging and drug development: An algorithm for decision making

      JOURNAL OF CLINICAL PHARMACOLOGY
    58. Wood, MD; Reavill, C; Trail, B; Wilson, A; Stean, T; Kennett, GA; Lightowler, S; Blackburn, TP; Thomas, D; Gager, TL; Riley, G; Holland, V; Bromidge, SM; Forbes, IT; Middlemiss, DN
      SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

      NEUROPHARMACOLOGY
    59. Akunne, HC; Zoski, KT; Whetzel, SZ; Cordon, JJ; Brandon, RM; Roman, F; Pugsley, TA
      Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant

      NEUROPHARMACOLOGY
    60. Werkman, TR; Kruse, CG; Nievelstein, H; Long, SK; Wadman, WJ
      In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs

      NEUROPHARMACOLOGY
    61. Marcus, MM; Mathe, JM; Nomikos, GG; Svensson, TH
      Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens

      NEUROPHARMACOLOGY
    62. Grunder, G; Vernaleken, I; Benkert, O
      Which properties make a neuroleptic "atypical"?

      NERVENARZT
    63. Khan, ZU; Koulen, P; Rubinstein, M; Grandy, DK; Goldman-Rakic, PS
      An astroglia-linked dopamine D2-receptor action in prefrontal cortex

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    64. Gainetdinov, RR; Mohn, AR; Bohn, LM; Caron, MG
      Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    65. Kulkarni, SK; Kaur, G
      Pharmacodynamics of drug-induced weight gain

      DRUGS OF TODAY
    66. Dean, B; Hussain, T; Scarr, E; Pavey, G; Copolov, DL
      Extended treatment with typical and atypical antipsychotic drugs - Differential effects on the densities of dopamine D-2-like and GABA(A) receptors in rat striatum

      LIFE SCIENCES
    67. Aloyo, VJ; Dave, KD; Rahman, T; Harvey, JA
      Selective and divergent regulation of cortical 5-HT2A receptors in rabbit

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    68. Pauwels, PJ; Finana, F; Tardif, S; Wurch, T; Colpaert, FC
      Dynamic dopamine-antagonist interactions at recombinant human dopamine D-2short receptor: Dopamine-bound versus antagonist-bound receptor states

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    69. Brun, P; Leonetti, M; Sotty, F; Steinberg, R; Soubrie, P; Renaud, B; Suaud-Chagny, MF
      Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist

      JOURNAL OF NEUROCHEMISTRY
    70. Yoshimura, R; Yanagihara, N; Hara, K; Nakamura, J; Toyohira, Y; Ueno, S; Izumi, F
      Dual phases of functional change in norepinephrine transporter in culturedbovine adrenal medullary cells by long-term treatment with clozapine

      JOURNAL OF NEUROCHEMISTRY
    71. Wilson, J; Lin, H; Fu, DY; Javitch, JA; Strange, PG
      Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation

      JOURNAL OF NEUROCHEMISTRY
    72. Anji, A; Hanley, NRS; Kumari, M; Hensler, JG
      The role of protein kinase C in the regulation of serotonin-2A receptor expression

      JOURNAL OF NEUROCHEMISTRY
    73. Ichikawa, J; Ishii, H; Bonaccorso, S; Fowler, WL; O'Laughlin, IA; Meltzer, HY
      5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-inducedcortical dopamine release

      JOURNAL OF NEUROCHEMISTRY
    74. Mouithys-Mickalad, A; Kauffmann, JM; Petit, C; Bruhwyler, J; Liao, Y; Wikstrom, H; Damas, J; Delarge, J; Deby-Dupont, G; Geczy, J; Liegeois, JF
      Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues

      JOURNAL OF MEDICINAL CHEMISTRY
    75. Rowley, M; Bristow, LJ; Hutson, PH
      Current and novel approaches to the drug treatment of schizophrenia

      JOURNAL OF MEDICINAL CHEMISTRY
    76. Rowley, M; Hallett, DJ; Goodacre, S; Moyes, C; Crawforth, J; Sparey, TJ; Patel, S; Marwood, R; Patel, S; Thomas, S; Hitzel, L; O'Connor, D; Szeto, N; Castro, JL; Hutson, PH; MacLeod, AM
      3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    77. Lopez-Gimenez, JF; Vilaro, MT; Palacios, JM; Mengod, G
      Mapping of 5-HT2A receptors and their mRNA in monkey brain: [H-3]MDL100,907 autoradiography and in situ hybridization studies

      JOURNAL OF COMPARATIVE NEUROLOGY
    78. Bhatnagar, A; Willins, DL; Gray, JA; Woods, J; Benovic, JL; Roth, BL
      The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    79. Inoue, A; Nakata, Y
      Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy

      JAPANESE JOURNAL OF PHARMACOLOGY
    80. Yoshio, R; Taniguchi, T; Itoh, H; Muramatsu, I
      Affinity of serotonin receptor antagonists and agonists to recombinant andnative alpha(1)-adrenoceptor subtypes

      JAPANESE JOURNAL OF PHARMACOLOGY
    81. Rodriguez, JJ; Garcia, DR; Nakabeppu, Y; Pickel, VM
      Enhancement of laminar FosB expression in frontal cortex of rats receivinglong chronic clozapine administration

      EXPERIMENTAL NEUROLOGY
    82. Boules, M; Warrington, L; Fauq, A; McCormick, D; Richelson, E
      Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    83. Takahashi, S; Horikomi, K; Kato, T
      MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    84. Hertel, P; Byskov, L; Didriksen, M; Arnt, J
      Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    85. Naidu, PS; Kulkarni, SK
      Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists

      EUROPEAN JOURNAL OF PHARMACOLOGY
    86. Habara, T; Hamamura, T; Miki, M; Ohashi, K; Kuroda, S
      M100907, a selective 5-HT2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    87. Matsumoto, RR; McCracken, KA; Pouw, B; Miller, J; Bowen, WD; Williams, W; De Costa, BR
      N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    88. Pauwels, PJ; Tardif, S; Wurch, T; Colpaert, FC
      Real-time analysis of dopamine: antagonist interactions at recombinant human D-2long receptor upon modulation of its activation state

      BRITISH JOURNAL OF PHARMACOLOGY
    89. Boules, M; McMahon, B; Warrington, L; Stewart, J; Jackson, J; Fauq, A; McCormick, D; Richelson, E
      Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties

      BRAIN RESEARCH
    90. Ichikawa, J; Dai, J; Meltzer, HY
      DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

      BRAIN RESEARCH
    91. Hatip-Al-Khatib, I; Mishima, K; Iwasaki, K; Fujiwara, M
      Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine

      BRAIN RESEARCH
    92. Pehek, EA; McFarlane, HG; Maguschak, K; Price, B; Pluto, CP
      M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex

      BRAIN RESEARCH
    93. Dawe, GS; Huff, KD; Vandergriff, JL; Sharp, T; O'Neill, MJ; Rasmussen, K
      Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-fos immunoreactivity

      BIOLOGICAL PSYCHIATRY
    94. Adams, BW; Moghaddam, B
      Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    95. Miller, DD; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD
      Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

      BIOLOGICAL PSYCHIATRY
    96. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    97. Kapur, S; Seeman, P
      Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor

      BIOLOGICAL PSYCHIATRY
    98. Sumiyoshi, T; Matsui, M; Yamashita, I; Nohara, S; Kurachi, M; Uehara, T; Sumiyoshi, S; Sumiyoshi, C; Meltzer, HY
      The effect of tandospirone, a serotonin(1A) agonist, on memory function inschizophrenia

      BIOLOGICAL PSYCHIATRY
    99. Lidow, MS; Song, ZM; Castner, SA; Allen, PB; Greengard, P; Goldman-Rakic, PS
      Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex

      BIOLOGICAL PSYCHIATRY
    100. Nopoulos, PC; Ceilley, JW; Gailis, EA; Andreasen, NC
      An MRI study of midbrain morphology in patients with schizophrenia: Relationship to psychosis, neuroleptics, and cerebellar neural circuitry

      BIOLOGICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 15:11:26